Issue Information.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 1, p. i, doi. 10.1002/cpdd.972
- Publication type:
- Article
Works matching IS 2160763X AND DT 2023 AND VI 12 AND IP 1
Results: 15
1
2
2023 CPDD Abstract Booklet.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 1, p. 1, doi. 10.1002/cpdd.1299
- Publication type:
- Article
3
Issue Information.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 1, p. 1, doi. 10.1002/cpdd.973
- Publication type:
- Article
4
Pharmacokinetic, Safety, and Tolerability Evaluations of Gepotidacin (GSK2140944) in Healthy Japanese Participants.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 1, p. 38, doi. 10.1002/cpdd.1192
- By:
- Publication type:
- Article
5
Validation of an Announced Telephone Pill Count Compared to a Home‐Visit Pill Count in People With Type 2 Diabetes or Cardiovascular Disease.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 1, p. 85, doi. 10.1002/cpdd.1185
- By:
- Publication type:
- Article
6
A Randomized, Open‐Label, Phase I Clinical Study of Dalpiciclib With Different Specifications After Process Modification in Healthy Chinese Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 1, p. 65, doi. 10.1002/cpdd.1182
- By:
- Publication type:
- Article
7
Pharmacokinetics of Single and Multiple Oral Administration of a Self‐emulsifying Formulation of Highly Purified Eicosapentaenoic Acid Ethyl Ester (MND‐2119) Compared With the Nonself‐emulsifying Formulation in Healthy Male Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 1, p. 107, doi. 10.1002/cpdd.1177
- By:
- Publication type:
- Article
8
Edaravone Administered Orally and Via Nasogastric Tube in Healthy Adults: A Comparative Bioavailability Phase 1 Study.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 1, p. 77, doi. 10.1002/cpdd.1175
- By:
- Publication type:
- Article
9
Pharmacokinetics and Bioequivalence of 2 Safinamide Tablets in Healthy Chinese Volunteers Under Fasting and Fed Conditions.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 1, p. 70, doi. 10.1002/cpdd.1157
- By:
- Publication type:
- Article
10
Pharmacokinetic and Pharmacodynamic Modeling and Simulation Analysis of Prasugrel in Healthy Male Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 1, p. 21, doi. 10.1002/cpdd.1172
- By:
- Publication type:
- Article
11
Evaluation of Deutetrabenazine's Potential to Delay Cardiac Repolarization Using Concentration‐QTc Analysis.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 1, p. 94, doi. 10.1002/cpdd.1161
- By:
- Publication type:
- Article
12
Pharmacokinetics, Bioavailability, and Swallowing Safety With Riluzole Oral Film.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 1, p. 57, doi. 10.1002/cpdd.1168
- By:
- Publication type:
- Article
13
Pharmacokinetic Comparison of Favipiravir Oral Solution and Tablet Formulations in Healthy Thai Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 1, p. 14, doi. 10.1002/cpdd.1149
- By:
- Publication type:
- Article
14
Pharmacokinetics and Bioequivalence of Fudosteine in Healthy Chinese Volunteers Under Fasting and Fed Conditions: A 4‐Way Replicate Crossover Study.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 1, p. 30, doi. 10.1002/cpdd.1137
- By:
- Publication type:
- Article
15
Pharmacokinetics of Icosapent Ethyl: An Open‐Label, Multiple Oral Dose, Parallel Design Study in Healthy Chinese Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 1, p. 6, doi. 10.1002/cpdd.1130
- By:
- Publication type:
- Article